4.6 Article

Efficacy of prolonged intravenous lidocaine infusion for postoperative movement-evoked pain following hepatectomy: a double-blinded, randomised, placebo-controlled trial

期刊

BRITISH JOURNAL OF ANAESTHESIA
卷 131, 期 1, 页码 113-121

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.bja.2023.03.026

关键词

hepatectomy; intravenous lidocaine; movement-evoked pain; pain at rest; prolonged infusion

向作者/读者索取更多资源

This study investigated the effect of prolonged intravenous lidocaine infusion on postoperative pain in patients undergoing hepatectomy. The results showed that prolonged lidocaine infusion reduced the incidence of moderate-to-severe movement-evoked pain and postoperative pulmonary complications, and decreased pain scores and opioid consumption.
Background: The analgesic effect of intravenous lidocaine varies with the duration of lidocaine infusion and surgery type. We tested the hypothesis that prolonged lidocaine infusion alleviates postoperative pain in patients recovering from hepatectomy over the first 3 postoperative days.Methods: Patients undergoing elective hepatectomy were randomly assigned to receive prolonged i.v. lidocaine treat-ment or placebo. The primary outcome was incidence of moderate-to-severe movement-evoked pain at 24 h post-operatively. The secondary outcomes included incidence of moderate-to-severe pain during movement and at rest throughout the first 3 postoperative days, postoperative opioid consumption, and pulmonary complications. Plasma lidocaine concentration was also monitored.Results: We enrolled 260 subjects. Intravenous lidocaine lowered the incidence of moderate-to-severe movement-evoked pain at 24 h and 48 h postoperatively (47.7% vs 67.7%, P=0.001; 38.5% vs 58.5%, P=0.001) and reduced movement-evoked pain scores (3.7 [1.7] vs 4.2 [1.6]; mean difference 0.5 [95% confidence interval {CI}: 0.1-0.9]; P=0.018) and morphine equivalent consumption (47.2 [16.7] mg vs 52.6 [19.2] mg; mean difference 5.4 mg [95% CI: 1.0-9.8]; P=0.016) at 24 h postoperatively. Lidocaine also lowered the incidence of postoperative pulmonary complications (23.1% vs 38.5%; P=0.007). Median plasma lidocaine concentrations were 1.5, 1.9, and 1.1 mg ml -1 (inter-quartile ranges: 1.1-2.1, 1.4-2.6, and 0.8-1.6, respectively) after bolus injection, at the end of the surgery, and 24 h postoperatively.Conclusions: Prolonged intravenous lidocaine infusion reduced the incidence of moderate-to-severe movement-evoked pain for 48 h after hepatectomy. However, the reduction in pain scores and opioid consumption by lidocaine was below the minimal clinically important difference.Clinical trial registration: NCT04295330.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据